Cerity Partners’s Sana Biotechnology SANA Stock Holding History

Cerity Partners’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.5K	Sell	21,336 -18,847	-47%	-$60.7K	﹤0.01%	3256
2026 Q1	$116K	Sell	40,183 -2,234	-5%	-$8.8K	﹤0.01%	3001
2025 Q4	$173K	Buy	42,417 +279	+0.7%	+$1.25K	﹤0.01%	2671
2025 Q3	$150K	Sell	42,138 -342	-0.8%	-$1.24K	﹤0.01%	2568
2025 Q2	$116K	Sell	42,480 -3,701	-8%	-$7.64K	﹤0.01%	2459
2025 Q1	$77.6K	Buy	46,181 +30,801	+200%	+$86.1K	﹤0.01%	2355
2024 Q4	$25.1K	Buy	+15,380	New	+$45.9K	﹤0.01%	2400

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Cerity Partners's SANA Position: Q2 2026 in Review

Cerity Partners reduced its Sana Biotechnology (SANA) stake by 47% in Q2 2026, selling an estimated $60.7K and leaving 21,336 shares worth $74.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3256.

Cerity Partners first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $173K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Cerity Partners held 21,336 shares of Sana Biotechnology worth $74.5K as of Q2 2026.
Cerity Partners sold 18,847 Sana Biotechnology shares in Q2 2026, an estimated $60.7K.
Sana Biotechnology made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3256 holding.
Cerity Partners first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
Cerity Partners's Sana Biotechnology position peaked at $173K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.